ADVERTISEMENT
Search

Pharmacy News

For smoking cessation, increasing dose may help improve abstinence

Most people who smoke don’t quit on their initial attempt. What’s the best course of action, then, if an initial smoking cessation attempt fails? Results from a randomized clinical trial published in JAMA Network found that for individuals who did not quit after being treated with varenicline, increasing the dosage enhanced abstinence. For nonabstainers who were initially treated with combination nicotine replacement therapy, a dosage increase or a switch to varenicline enhanced abstinence.

Under new law, pharmacist scope of practice expands in Tennessee

Governor Bill Lee of Tennessee signed legislation that expands pharmacists’ scope of practice in the state. The law took effect immediately upon the governor’s signature on May 1.

AHA wants to engage pharmacists in AFib care

A new initiative from the American Heart Association (AHA) aims to educate and engage pharmacists in caring for patients with AFib.

Migraine associated with PPIs and other acid suppressing medications, says study

A study of more than 11,000 U.S. adults suggests an association between acid-suppression therapy, including PPIs, H2RAs, and generic antacids, and an increased risk of migraine and severe headaches compared with people who do not take these medications. The risk was 70% higher for those using PPIs, 40% higher for those taking H2RAs, and 30% higher for generic antacids.

Analysis finds total reversal in heart failure deaths

Authors of a research letter in JAMA Cardiology report that declines in heart failure–related mortality from 1999 to 2012 have been entirely undone by reversals from 2012 to 2021.

RSS
123578910Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT